| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |